The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation

REFERENCES

• Bae, S. C., E. Takahashi, Y. W. Zhang, E. Ogawa, K. Shigesada, Y. Namba, M. Satake, and Y. Ito 1995. Cloning, mapping and expression of PEBP2 alpha C, a third gene encoding the mammalian Runt domain. Gene 159: 245–248.
   PubMed Web of Science ®Google Scholar
• Banaiee, N., et al. Unpublished data.
   Google Scholar
• Birkenmeier, E. H., B. Gwynn, S. Howard, J. Jerry, J. I. Gordon, W. H. Landschulz, and S. L. McKnight 1989. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev. 3: 1146–1156.
   PubMed Web of Science ®Google Scholar
• Cameron, S., D. S. Taylor, E. C. TePas, N. A. Speck, and B. Mathey-Prevot 1994. Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo footprinting. Blood 83: 2851–2859.
   PubMed Web of Science ®Google Scholar
• Cao, Z., R. M. Umek, and S. L. McKnight 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5: 1538–1552.
   PubMed Web of Science ®Google Scholar
• Castilla, L. H., C. Wijmenga, Q. Wang, T. Stacy, N. A. Speck, M. Eckhaus, M. Marin-Padilla, F. S. Collins, A. Wynshaw-Boris, and P. P. Liu 1996. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 87: 687–696.
   PubMed Web of Science ®Google Scholar
• Daher, K. A., R. I. Lehrer, T. Ganz, and M. Kronenberg 1988. Isolation and characterization of human defensin cDNA clones. Proc. Natl. Acad. Sci. USA 85: 7327–7331.
   PubMed Web of Science ®Google Scholar
• Downing, J. R., D. R. Head, A. M. Curcio-Brint, M. G. Hulshof, T. A. Motroni, S. C. Raimondi, A. J. Carroll, H. A. Drabkin, C. Willman, K. S. Theil, et al. 1993. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood 81: 2860–2865.
   PubMed Web of Science ®Google Scholar
• Erickson, P., J. Gao, K. S. Chang, T. Look, E. Whisenant, S. Raimondi, R. Lasher, J. Trujillo, J. Rowley, and H. Drabkin 1992. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80: 1825–1831.
   PubMed Web of Science ®Google Scholar
• Erickson, P. F., G. Dessev, R. S. Lasher, G. Philips, M. Robinson, and H. A. Drabkin 1996. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease. Blood 88: 1813–1823.
   PubMed Web of Science ®Google Scholar
• Erickson, P. F., M. Robinson, G. Owens, and H. A. Drabkin 1994. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor. Cancer Res. 54: 1782–1786.
   PubMed Web of Science ®Google Scholar
• Fears, S., M. Gavin, D. E. Zhang, C. Hetherington, Y. Ben-David, J. D. Rowley, and G. Nucifora 1997. Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter. Proc. Natl. Acad. Sci. USA 94: 1949–1954.
   PubMed Web of Science ®Google Scholar
• Feinstein, P. G., K. Kornfeld, D. S. Hogness, and R. S. Mann 1995. Identification of homeotic target genes in Drosophila melanogaster including nervy, a proto-oncogene homologue. Genetics 140: 573–586.
   PubMedGoogle Scholar
• Frank, R., J. Zhang, H. Uchida, S. Meyers, S. W. Hiebert, and S. D. Nimer 1995. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene 11: 2667–2674.
   PubMed Web of Science ®Google Scholar
• Ganz, T., M. E. Selsted, and R. I. Lehrer 1990. Defensins. Eur. J. Haematol. 44: 1–8.
   PubMed Web of Science ®Google Scholar
• Golub, T. R., G. F. Barker, S. K. Bohlander, S. W. Hiebert, D. C. Ward, P. Bray-Ward, E. Morgan, S. C. Raimondi, J. D. Rowley, and D. G. Gilliland 1995. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 92: 4917–4921.
   PubMed Web of Science ®Google Scholar
• Golub, T. R., G. F. Barker, M. Lovett, and D. G. Gilliland 1994. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77: 307–316.
   PubMed Web of Science ®Google Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2: 1044–1051.
   PubMed Web of Science ®Google Scholar
• Gottschalk, L. R., and J. M. Leiden 1990. Identification and functional characterization of the human T-cell receptor beta gene transcriptional enhancer: common nuclear proteins interact with the transcriptional regulatory elements of the T-cell receptor alpha and beta genes. Mol. Cell. Biol. 10: 5486–5495.
   PubMedGoogle Scholar
• Gross, C. T., and W. McGinnis 1996. DEAF-1, a novel protein that binds an essential region in a Deformed response element. EMBO J. 15: 1961–1970.
   PubMed Web of Science ®Google Scholar
• Hiebert, S. W., M. Blake, J. Azizkhan, and J. R. Nevins 1991. Role of E2F transcription factor in E1A-mediated trans activation of cellular genes. J. Virol. 65: 3547–3552.
   PubMedGoogle Scholar
• Hiebert, S. W., S. P. Chellappan, J. M. Horowitz, and J. R. Nevins 1992. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6: 177–185.
   PubMed Web of Science ®Google Scholar
• Hiebert, S. W., and S. Meyers. Unpublished data.
   Google Scholar
• Hiebert, S. W., G. Packham, D. K. Strom, R. Haffner, M. Oren, G. Zambetti, and J. L. Cleveland 1995. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol. Cell. Biol. 15: 6864–6874.
   PubMed Web of Science ®Google Scholar
• Hiebert, S. W., W. Sun, J. N. Davis, T. Golub, S. Shurtleff, A. Buijs, J. R. Downing, G. Grosveld, M. F. Roussell, D. G. Gilliland, N. Lenny, and S. Meyers 1996. The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription. Mol. Cell. Biol. 16: 1349–1355.
   PubMed Web of Science ®Google Scholar
• Hohaus, S., M. S. Petrovick, M. T. Voso, Z. Sun, D. E. Zhang, and D. G. Tenen 1995. PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene. Mol. Cell. Biol. 15: 5830–5845.
   PubMed Web of Science ®Google Scholar
• Hsiang, Y. H., D. Spencer, S. Wang, N. A. Speck, and D. H. Raulet 1993. The role of viral enhancer “core” motif-related sequences in regulating T cell receptor-gamma and -delta gene expression. J. Immunol. 150: 3905–3916.
   PubMed Web of Science ®Google Scholar
• Johnson, P. F., W. H. Landschulz, B. J. Graves, and S. L. McKnight 1987. Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses. Genes Dev. 1: 133–146.
   PubMed Web of Science ®Google Scholar
• Klampfer, L., J. Zhang, A. O. Zelenetz, H. Uchida, and S. D. Nimer 1996. The AML1/ETO fusion protein activates transcription of BCL-2. Proc. Natl. Acad. Sci. USA 93: 14059–14064.
   PubMed Web of Science ®Google Scholar
• Lehrer, R. I., T. Ganz, and M. E. Selsted 1991. Defensins: endogenous antibiotic peptides of animal cells. Cell 64: 229–230.
   PubMed Web of Science ®Google Scholar
• Lehrer, R. I., A. K. Lichtenstein, and T. Ganz 1993. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 11: 105–128.
   PubMed Web of Science ®Google Scholar
• Lenny, N., S. Meyers, and S. W. Hiebert 1995. Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene 11: 1761–1769.
   PubMedGoogle Scholar
• Levanon, D., V. Negreanu, Y. Bernstein, I. Bar-Am, L. Avivi, and Y. Groner 1994. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 23: 425–432.
   PubMed Web of Science ®Google Scholar
• Linzmeier, R., D. Michaelson, L. Liu, and T. Ganz 1993. The structure of neutrophil defensin genes. FEBS Lett. 326: 299–300.
   PubMedGoogle Scholar
• Liu, P., S. A. Tarle, A. Hajra, D. F. Claxton, P. Marlton, M. Freedman, M. J. Siciliano, and F. S. Collins 1993. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 261: 1041–1044.
   PubMed Web of Science ®Google Scholar
• Meyers, S., J. R. Downing, and S. W. Hiebert 1993. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol. Cell. Biol. 13: 6336–6345.
   PubMed Web of Science ®Google Scholar
• Meyers, S., and S. W. Hiebert 1995. Indirect and direct disruption of transcriptional regulation in cancer: E2F and AML-1. Crit. Rev. Eukaryotic Gene Expr. 5: 365–383.
   PubMedGoogle Scholar
• Meyers, S., N. Lenny, and S. W. Hiebert 1995. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol. Cell. Biol. 15: 1974–1982.
   PubMed Web of Science ®Google Scholar
• Meyers, S., N. Lenny, W. Sun, and S. W. Hiebert 1996. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene 13: 303–312.
   PubMed Web of Science ®Google Scholar
• Mitani, K., S. Ogawa, T. Tanaka, H. Miyoshi, M. Kurokawa, H. Mano, Y. Yazaki, M. Ohki, and H. Hirai 1994. Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO J. 13: 504–510.
   PubMed Web of Science ®Google Scholar
• Miyoshi, H., T. Kozu, K. Shimizu, K. Enomoto, N. Maseki, Y. Kaneko, N. Kamada, and M. Ohki 1993. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 12: 2715–2721.
   PubMed Web of Science ®Google Scholar
• Miyoshi, H., K. Shimizu, T. Kozu, N. Maseki, Y. Kaneko, and M. Ohki 1991. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88: 10431–10434.
   PubMed Web of Science ®Google Scholar
• Morishita, K., D. S. Parker, M. L. Mucenski, N. A. Jenkins, N. G. Copeland, and J. N. Ihle 1988. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 54: 831–840.
   PubMed Web of Science ®Google Scholar
• Nisson, P. E., P. C. Watkins, and N. Sacchi 1992. Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. Cancer Genet. Cytogenet. 63: 81–88.
   PubMed Web of Science ®Google Scholar
• Nuchprayoon, I., S. Meyers, L. M. Scott, J. Suzow, S. Hiebert, and A. D. Friedman 1994. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol. Cell. Biol. 14: 5558–5568.
   PubMed Web of Science ®Google Scholar
• Nucifora, G., C. R. Begy, P. Erickson, H. A. Drabkin, and J. D. Rowley 1993. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1. Proc. Natl. Acad. Sci. USA 90: 7784–7788.
   PubMed Web of Science ®Google Scholar
• Nucifora, G., C. R. Begy, H. Kobayashi, D. Roulston, D. Claxton, J. Pedersen-Bjergaard, E. Parganas, J. N. Ihle, and J. D. Rowley 1994. Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc. Natl. Acad. Sci. USA 91: 4004–4008.
   PubMed Web of Science ®Google Scholar
• Nucifora, G., D. J. Birn, P. Erickson, J. Gao, M. M. LeBeau, H. A. Drabkin, and J. D. Rowley 1993. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood 81: 883–888.
   PubMed Web of Science ®Google Scholar
• Nucifora, G., D. J. Birn, R. D. Espinosa, P. Erickson, M. M. LeBeau, D. Roulston, T. W. McKeithan, H. Drabkin, and J. D. Rowley 1993. Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood 81: 2728–2734.
   PubMed Web of Science ®Google Scholar
• Oelgeschlager, M., I. Nuchprayoon, B. Luscher, and A. D. Friedman 1996. C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol. Cell. Biol. 16: 4717–4725.
   PubMed Web of Science ®Google Scholar
• Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ito 1993. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Natl. Acad. Sci. USA 90: 6859–6863.
   PubMed Web of Science ®Google Scholar
• Okuda, T., J. van Deursen, S. W. Hiebert, G. Grosveld, and J. R. Downing 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84: 321–330.
   PubMed Web of Science ®Google Scholar
• Owens, G. P., W. E. Hahn, and J. J. Cohen 1991. Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol. Cell. Biol. 11: 4177–4188.
   PubMed Web of Science ®Google Scholar
• Petrovick, M. S., S. W. Hiebert, A. D. Friedman, C. J. Hetherington, D. G. Tenen, and D. E. Zhang. Multiple functional domains of AML1: PU.1 and C/EBP-α cooperate with different regions of AML1. Submitted for publication.
   Google Scholar
• Redondo, J. M., J. L. Pfohl, and M. S. Krangel 1991. Identification of an essential site for transcriptional activation within the human T-cell receptor delta enhancer. Mol. Cell. Biol. 11: 5671–5680.
   PubMedGoogle Scholar
• Rhoades, K. L., C. J. Hetherington, J. D. Rowley, S. W. Hiebert, G. Nucifora, D. G. Tenen, and D. E. Zhang 1996. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Proc. Natl. Acad. Sci. USA 93: 11895–11900.
   PubMed Web of Science ®Google Scholar
• Romana, S. P., M. Mauchauffe, M. Le Coniat, I. Chumakov, D. Le Paslier, R. Berger, and O. A. Bernard 1995. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85: 3662–3670.
   PubMed Web of Science ®Google Scholar
• Romana, S. P., H. Poirel, M. Leconiat, M. A. Flexor, M. Mauchauffe, P. Jonveaux, E. A. Macintyre, R. Berger, and O. A. Bernard 1995. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86: 4263–4269.
   PubMed Web of Science ®Google Scholar
• Rubin, C. M., R. A. Larson, J. Anastasi, J. N. Winter, M. Thangavelu, J. W. Vardiman, J. D. Rowley, and M. M. Le Beau 1990. t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 76: 2594–2598.
   PubMed Web of Science ®Google Scholar
• Sacchi, N., P. E. Nisson, P. C. Watkins, F. Faustinella, J. Wijsman, and A. Hagemeijer 1994. AML1 fusion transcripts in t(3;21) positive leukemia: evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AML1 transcripts. Genes Chromosomes Cancer 11: 226–236.
   PubMedGoogle Scholar
• Sawyers, C. L., C. T. Denny, and O. N. Witte 1991. Leukemia and the disruption of normal hematopoiesis. Cell 64: 337–350.
   PubMed Web of Science ®Google Scholar
• Scott, L. M., C. I. Civin, P. Rorth, and A. D. Friedman 1992. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80: 1725–1735.
   PubMed Web of Science ®Google Scholar
• Shurtleff, S. A., A. Buijs, F. G. Behm, J. E. Rubnitz, S. C. Raimondi, M. L. Hancock, G. C. Chan, C. H. Pui, G. Grosveld, and J. R. Downing 1995. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9: 1985–1989.
   PubMed Web of Science ®Google Scholar
• Shurtleff, S. A., S. Meyers, S. W. Hiebert, S. C. Raimondi, D. R. Head, C. L. Willman, S. Wolman, M. L. Slovak, A. J. Carroll, F. Behm, et al. 1995. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. Blood 85: 3695–3703.
   PubMed Web of Science ®Google Scholar
• Smith, L. T., S. Hohaus, D. A. Gonzalez, S. E. Dziennis, and D. G. Tenen 1996. PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 88: 1234–1247.
   PubMed Web of Science ®Google Scholar
• Suzow, J., and A. D. Friedman 1993. The murine myeloperoxidase promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, myeloid nuclear factor 1 (MyNF1). Mol. Cell. Biol. 13: 2141–2151.
   PubMed Web of Science ®Google Scholar
• Tanaka, T., M. Kurokawa, K. Ueki, K. Tanaka, Y. Imai, K. Mitani, K. Okazaki, N. Sagata, Y. Yazaki, Y. Shibata, T. Kadowaki, and H. Hirai 1996. The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Mol. Cell. Biol. 16: 3967–3979.
   PubMed Web of Science ®Google Scholar
• Uchida, H., J. Zhang, and S. D. Nimer 1997. AML1A and AML1B can transactivate the human IL-3 promoter. J. Immunol. 158: 2251–2258.
   PubMed Web of Science ®Google Scholar
• Wang, Q., T. Stacy, M. Binder, M. Marin-Padilla, A. H. Sharpe, and N. A. Speck 1996. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. USA 93: 3444–3449.
   PubMed Web of Science ®Google Scholar
• Wang, Q., T. Stacy, J. D. Miller, A. F. Lewis, T. L. Gu, X. Huang, J. H. Bushweller, J. C. Bories, F. W. Alt, G. Ryan, P. P. Liu, A. Wynshaw-Boris, M. Binder, M. Marin-Padilla, A. H. Sharpe, and N. A. Speck 1996. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell 87: 697–708.
   PubMed Web of Science ®Google Scholar
• Wang, S., Q. Wang, B. E. Crute, I. N. Melnikova, S. R. Keller, and N. A. Speck 1993. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13: 3324–3339.
   PubMed Web of Science ®Google Scholar
• Westendorf, J. J., and S. W. Hiebert. Unpublished data.
   Google Scholar
• Yamamoto, C. M., et al. Unpublished data.
   Google Scholar
• Yergeau, D. A., C. J. Hetherington, Q. Wang, P. Zhang, A. H. Sharpe, M. Binder, M. Marin-Padilla, D. G. Tenen, N. A. Speck, and D. E. Zhang 1997. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet. 15: 303–306.
   PubMed Web of Science ®Google Scholar
• Yount, N. Y., M. S. Wang, J. Yuan, N. Banaiee, A. J. Ouellette, and M. E. Selsted 1995. Rat neutrophil defensins. Precursor structures and expression during neutrophilic myelopoiesis. J. Immunol. 155: 4476–4484.
   PubMedGoogle Scholar
• Zeng, C., A. J. van Wijnen, J. L. Stein, S. Meyers, W. Sun, L. Shopland, J. B. Lawrence, S. Penman, J. B. Lian, G. S. Stein, and S. W. Hiebert 1997. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc. Natl. Acad. Sci. USA 94: 6746–6751.
   PubMedGoogle Scholar
• Zhang, D.-E., K. Fujioka, C. J. Hetherington, L. H. Shapiro, H.-M. Chen, A. T. Look, and D. G. Tenen 1994. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol. Cell. Biol. 14: 8085–8095.
   PubMed Web of Science ®Google Scholar
• Zhang, D.-E., C. J. Hetherington, S. Meyers, K. L. Rhoades, C. J. Larson, H.-M. Chen, S. W. Hiebert, and D. G. Tenen 1996. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBFα2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol. Cell. Biol. 16: 1231–1240.
   PubMed Web of Science ®Google Scholar
• Zhang, D. E., S. Hohaus, M. T. Voso, H. M. Chen, L. T. Smith, C. J. Hetherington, and D. G. Tenen 1996. Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters. Curr. Top. Microbiol. Immunol. 211: 137–147.
   PubMed Web of Science ®Google Scholar
• Zhang, D. E., P. Zhang, N. D. Wang, C. J. Hetherington, G. J. Darlington, and D. G. Tenen 1997. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. Proc. Natl. Acad. Sci. USA 94: 569–574.
   PubMed Web of Science ®Google Scholar